The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade.
News|Articles|November 21, 2024
Why Leading Pharma Companies are Adopting CRMs with AI Capabilities
Author(s)Close-Up., US
In today’s competitive pharma landscape, success goes beyond meeting quotas. Forward-thinking companies need to adopt AI-powered tools to make informed smarter decisions, strengthen relationships with HCPs, increase sales performance, and optimize the sales reps time in the field
Advertisement
Advertisement
Related to this article
Rebate delays could force 340B hospitals to pay upfront and wait months for credit, distorting drug spend on the books. Valerie Bandy, PharmD, of Tecsys explains the fallout.
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
DSCSA data exchange has matured into daily operations, but the coming NDC-12 shift and a national licensure standard add new work streams before old ones are fully settled.
Liberty Dewey of Cardinal Health breaks down the NDC-12 transition timeline, the four work streams driving it and why the biggest risk sits in trading partner handoffs.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
An FTC settlement moved one PBM aggregator onshore, but manufacturers still lack contract-level clarity on what affiliated fees actually buy.
Simvera PSP applies queueing science so manufacturers can test the cost and patient impact of hub staffing decisions before locking them in.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Independent Pharmacies Sue Express Scripts, Novo Taps Anthropic, Pharma Joins Clean Heat
2
The PBM Entity No Pharmaceutical Company Directly Contracted With
3
White House Extends MFN Pricing to Every State Medicaid Program
4
FAQ: What's Next for Pharma Traceability After DSCSA
5